myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Sponsors
Research Center for Prevention of Cardiovascular Disease, Iran university of medical sciences
Eligibility
Sex/Gender
All
Age
35 Years to 65 Years
Inclusion criteria
Inclusion criteria: Having the consent and willingness to cooperate in the project Age range 35 to 65 years Pass at least 2 months from the time of the first heart attack BMI< 30 Kg/m2
Exclusion criteria
Exclusion criteria: consumption of vitamin supplements, antioxidants or omega-3 in the last 3 months consumption of nonsteroidal anti-inflammatory drugs in the last 3 months Having a history of chronic inflammatory, kidney, liver and thyroid disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICAM-1. Timepoint: At the baseline and after 8 weeks of intervention. Method of measurement: The level of ICAM-1 in serum with ELISA method. | — |
Secondary
| Measure | Time frame |
|---|---|
| VCAM-1. Timepoint: At the baseline and after 8 weeks of intervention. Method of measurement: The level of VCAM-1 in serum with ELISA method.;Systolic blood pressure. Timepoint: At the baseline and after 8 weeks of intervention. Method of measurement: sphygmomanometer (mmHg).;Diastolic blood pressure. Timepoint: At the baseline and after 8 weeks of intervention. Method of measurement: sphygmomanometer (mmHg). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hashem Sezavar Seyedi Jandaghi
Iran University of Medical Sciences
Outcome results
None listed